is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute...
The St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical-Biological Agency (FMBA) has filed an application with the Health Ministry...
The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund, investor in...
The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn 2023, Moderna's Chief Executive Officer...
International travellers who have had two doses of the Russian Sputnik V vaccine will be permitted to enter Australia now that the Therapeutic Goods...